Compare EVGO & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVGO | ACB |
|---|---|---|
| Founded | 2010 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Pharmaceuticals and Biotechnology |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 195.6M | 232.3M |
| IPO Year | 2020 | 2016 |
| Metric | EVGO | ACB |
|---|---|---|
| Price | $1.46 | $3.88 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $5.23 | N/A |
| AVG Volume (30 Days) | ★ 3.3M | 963.0K |
| Earning Date | 05-05-2026 | 06-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 24.39 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $54,588,000.00 | N/A |
| Revenue This Year | $16.45 | $6.31 |
| Revenue Next Year | $29.44 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 145.74 | N/A |
| 52 Week Low | $1.23 | $2.56 |
| 52 Week High | $5.18 | $6.67 |
| Indicator | EVGO | ACB |
|---|---|---|
| Relative Strength Index (RSI) | 50.22 | 59.47 |
| Support Level | $1.42 | $3.68 |
| Resistance Level | $1.52 | $3.91 |
| Average True Range (ATR) | 0.09 | 0.13 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 79.31 | 40.43 |
EVgo Inc is an EV fast charging provider. The company deploys charging infrastructure by partnering with retailers, grocery stores, restaurants, gas stations, rideshare operators, and autonomous vehicle companies across the U.S., and serves the EV commercial segment by deploying fleet-charging solutions for light-duty EV fleets at depot locations, off-site charging hubs, or through its public network. It also owns PlugShare, a platform for EV drivers to locate public charging stations, plan trips and share charging experiences, which also provides charging location data licensing, infrastructure analysis, and EV driver research. It also derives revenue from the sale of regulatory credits earned from participation in LCFS programs and other carbon or emissions trading schemes in the U.S.
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.